Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 601-612 of 4,306
Drug study icon
CompletedNCT02186769

LY03004 Compared to Risperdal® Consta® for schizophrenia

This study is completed in the United States. It is testing LY03004 Compared to Risperdal® Consta® for schizophrenia.

Multiple locations, including Orange County
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT00325689

Aripiprazole Used as Dual Therapy in the Treatement of people with Chronic Stable Schizophrenia or Schizoaffective Disorder.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02091388

Bioavailability of LY03004 and Risperdal® Consta®

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT03708315

BXCL501 for Agitation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00672464

Cardio Risk of Acute Schizophrenia Olanzapine Duke

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Butner
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Duke University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT07427485

Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Waiting List Controlled Feasibility Study

This study is completed in Italy. It is testing Cognitive Rehabilitation With Immersive Virtual Reality (IVR) for schizophrenia.

In Torre del Greco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 67 Years
Countries
Italy
Sponsor
Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01521026

Cognitive Training for people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01368458

Conversion to Antipsychotic Monotherapy

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 75 Years
Countries
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.